提高慢性乙型肝炎患者IFN-α治疗的应答率
被引量：1
摘要
提高α干扰素(IFN-α)对于慢性乙型肝炎(CHB)患者抗病毒治疗的应答率,是当今临床研究的热点,本文即对其相关问题进行讨论.
出处
《临床肝胆病杂志》
CAS
北大核心
2003年第5期266-268,共3页
Journal of Clinical Hepatology
参考文献15
-
1Lok ASF,Heathente EJ,Hoofnagle JH.Management of hepatitis B 2000,summary of a Workshop[J].Gatroenterology,2001,120(7):1828-1853
-
2Wong DK,Cheung AM,O'Rourke K,et al.Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B[J].Ann Intern Med,1993,119(4):312-323
-
3Lok ASF, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2001, 34(6) : 1225 - 1241.
-
4Perrillo RP.Acute flares in chronic hepatitis B:the natural and unnatural history of an immunologically mediated infection[J].Gastroenterology,2001,120(4):1009-1022
-
5Nair S,Perrillo RP.Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B:is sustained clearance of HBV DNA Dependent on levels of pretreatment viremia[J]?Hepatology,2001,34(5):1021-1026
-
6Perrillo RP,Schiff ER,Davis GL,et al.A randomized,controlled trial of interferon alfa - 2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B.The Hepatitis International Therapy Group[J].N Engl J Med,1990,323(5):295-301
-
7Lok ASF, Wu PC, Lai CL, et al. Contrdled trial of interferon with or without prednisone printing for chronic hepatitis B[J].Gastroenterology,1992, 102(6) :2091-2097.
-
8Janssen HL,Gerken G,Carreno V,et al.Interferon alpha for chronic hepatitis B infection:increased efficacy of prolonged treatment.The European Concerted Action on Viral Hepatitis(EUROHEP)[J].Hepatology,1999,30(1):238-243
-
9Oliveri F,Santantonio T,Bellati G,et al.Long term response to therapy of chronic anti-HBe positive hepatitis B is poor independent of type and schedule of interferon[J].Am J Gestroenterol,1999,94(5):1366-1372
-
10Davis GL.Chronic hepatitis[M].In:Kaplowitz N, ed. Liver and Biliary Disease. 2 -nd ed. Baltimore: Williams & Wilkina, 1996. 330-337.
同被引文献5
-
1赵有蓉,张定凤,郭树华,邹淑碧,张全海,曾维群,何华.重组干扰素治疗慢性乙型肝炎1～7年随访[J].中华肝脏病杂志,1997,5(4):216-218. 被引量：35
-
2邱望龙,崔雪莲,皇甫丽,黄四邑,潘志灵,刘梅花.干扰素-α1b治疗前C区变异株引起的慢性乙型肝炎的疗效[J].中华传染病杂志,1999,17(3):193-194. 被引量：8
-
3马为民,陆坚,蒋小玲,周伯平,敖飞健.干扰素α-1b治疗慢性乙型肝炎的疗效及其预测因素分析[J].中华传染病杂志,2001,19(3):148-151. 被引量：63
-
4李秀兰,崔振宇,曹传梅,蒋荣猛,刘玉英.干扰素α治疗慢性乙型肝炎10年随访研究[J].中华内科杂志,2001,40(11):767-768. 被引量：5
-
5何清,陈守春,王松,蒋小玲,许诚,张斌,李丽雄,唐红,杨尧,王文雅,赵连三.干扰素治疗慢性乙型肝炎临床反应及疗效预测指标的研究[J].中华肝脏病杂志,2003,11(4):215-218. 被引量：37
-
1叶军.HBeAg阳性慢性乙型肝炎的治疗[J].肝脏,2003,8(3):42-43. 被引量：1
-
2常树珍,程华,陈平.丙型病毒性肝炎干扰素治疗现状[J].传染病信息,2003,16(3):140-141.
-
3舒欣,崇雨田.慢性乙型病毒性肝炎抗病毒治疗的体会[J].新医学,2002,33(4):199-200. 被引量：6
-
4蒲宏涛,杜立峰.大剂量基因工程αA干扰素治疗肾综合征出血热双盲对比研究[J].中华实验和临床病毒学杂志,1996,10(3):296-297. 被引量：2
-
5祝平安,梁欣泉.原发性血小板增多症13例疗效分析[J].医学临床研究,2004,21(2):160-161. 被引量：2
-
6α干扰素治疗慢性乙型和丙型肝炎[J].现代实用医学,2001,13(1):11-11.
-
7李如成,庞立,陆学华.a干扰素联合甘利欣治疗慢性乙型肝炎疗效观察[J].河北医学,2007,13(2):184-187.
-
8郭斯敏,谢青.HBeAg阴性慢性乙型肝炎的药物治疗[J].肝脏,2003,8(3):43-44.
-
9张国海,梁丽英,许瑞安.RNA干扰抗丙型肝炎病毒的研究进展[J].重庆医学,2010,39(14):1914-1917. 被引量：2
-
10于东红.a干扰素治疗慢性乙肝不良反应的观察及护理[J].黑龙江医药,2009,22(5):732-733. 被引量：3
